MT-ND6 — Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 6
The MT-ND6 gene is like an instruction manual for making a protein called NADH dehydrogenase 6. This protein is a vital part of a large machine in your cells called Complex I, which is located in the mitochondria—the "powerhouses" of the cells. Complex I helps convert the energy from the food you eat into a form of energy that your cells can use to function properly. When there is a mutation or change in the MT-ND6 gene, the Complex I machine doesn't work correctly. This means your cells can't produce enough energy, and they might also build up harmful molecules called reactive oxygen species. Because the eyes and the brain require a lot of energy, they are usually the most affected by these changes. This can lead to conditions like Leber hereditary optic neuropathy (LHON), which causes vision loss, or Leigh syndrome, which affects the brain and nervous system.
Gene description: The MT-ND6 gene provides instructions for making the NADH dehydrogenase 6 protein, which is a core subunit of the mitochondrial respiratory chain Complex I. Mutations in this gene disrupt mitochondrial energy production and are primarily associated with Leber hereditary optic neuropathy (LHON) and Leigh syndrome.
Patient and family guide: The MT-ND6 gene is like an instruction manual for making a protein called NADH dehydrogenase 6. This protein is a vital part of a large machine in your cells called Complex I, which is located in the mitochondria—the "powerhouses" of the cells. Complex I helps convert the energy from the food you eat into a form of energy that your cells can use to function properly. When there is a mutation or change in the MT-ND6 gene, the Complex I machine doesn't work correctly. This means your cells can't produce enough energy, and they might also build up harmful molecules called reactive oxygen species. Because the eyes and the brain require a lot of energy, they are usually the most affected by these changes. This can lead to conditions like Leber hereditary optic neuropathy (LHON), which causes vision loss, or Leigh syndrome, which affects the brain and nervous system.
Gene function: The MT-ND6 gene encodes the NADH dehydrogenase 6 protein, a crucial component of the mitochondrial inner membrane's Complex I. This protein is essential for the assembly and function of Complex I, which catalyzes the first step of the electron transport chain, transferring electrons from NADH to ubiquinone to drive ATP synthesis.
Protein structure: The MT-ND6 protein is an 18 kDa polypeptide composed of 172 amino acids. It has an L-shaped structure featuring a long, highly hydrophobic transmembrane domain that forms the core of the Complex I transmembrane region, and a hydrophilic domain for the peripheral arm.
Molecular function: The MT-ND6 protein is a core subunit of the respiratory chain Complex I (NADH:ubiquinone oxidoreductase). It belongs to the minimal assembly of core proteins required to catalyze the dehydrogenation of NADH and the subsequent transfer of electrons to ubiquinone (coenzyme Q10). During this process, electrons are transferred through a series of iron-sulfur clusters to ubiquinone, reducing it to ubiquinol. This electron flow induces conformational changes in the complex, enabling it to pump protons out of the mitochondrial matrix across the inner mitochondrial membrane. This creates an electrochemical gradient that provides the energy necessary for ATP production by ATP synthase.
Mutation spectrum: The mutation spectrum of MT-ND6 primarily includes missense mutations, such as T14484C (Met64Val) and G14459A (Ala72Val), which are strongly associated with LHON and Leigh syndrome. Frameshift mutations and other point mutations have also been reported in various mitochondrial disorders and some cancers.
Clinical significance: Mutations in the MT-ND6 gene, such as the common T14484C variant, prevent Complex I from interacting normally with ubiquinone. This disruption impairs the generation of ATP through oxidative phosphorylation and may increase the production of potentially harmful reactive oxygen species (ROS) within mitochondria. These biochemical defects lead to cellular energy failure and oxidative stress, which are particularly damaging to tissues with high energy demands, such as the optic nerve and the brain. Consequently, these mutations cause diseases like Leber hereditary optic neuropathy (LHON), characterized by vision loss, and Leigh syndrome, a progressive brain disorder.
Inheritance: Mitochondrial
Chromosomal location: Mitochondrial (MT)
Research and therapeutic approaches: Therapeutic approaches for MT-ND6 mutations are currently limited but actively researched. Strategies include optimized allotopic expression of the mitochondrial ND6 transgene to restore Complex I function and reduce apoptosis. Other approaches involve the use of reactive oxygen species (ROS) scavengers and antioxidants to mitigate oxidative stress, as well as experimental gene therapies aiming to correct the underlying mitochondrial DNA defect.